Liver Cancer
Copyright ©The Author(s) 2005.
World J Gastroenterol. Jul 7, 2005; 11(25): 3850-3854
Published online Jul 7, 2005. doi: 10.3748/wjg.v11.i25.3850
Table 1 Expression of DEK, cyclin D1, IGF-II, GPC3, rpP0 mRNAs in HCC and adjacent noncancerous liver tissues
Cyclin D1a
GPC3c
DEKe
IGFg
rpP0i
TNTNTNTNTN
Positive281324725528122610
Negative419825727420622
Table 2 Expression of DEK, cyclin D1, IGF-II, GPC3, rpP0 mRNAs in well- and poorly-differentiated HCC
Cyclin D1
GPC3
DEK
IGF-II
rpP0
+-+-+-+-+-
Well-differentiated HCC6363816372
Poor-differentiated HCC221185176221194
Total284248257284266
Table 3 Expression of DEK, cyclin D1, IGF-II, GPC3, rpP0 mRNAs in HCC with AFP negative and positive HCC tissue
nCyclin D1+GPC3+DEK+IGF-II+rpP0+
AFP(-)1089999
AFP(+)222015161917
Total322824252826
Table 4 Expression of DEK, cyclin D1, IGF-II, GPC3, rpP0 mRNAs in HCC and adjacent noncancerous liver tissues by multiplex RT-PCR Groups
nPositive reaction
Negative reaction
Anyone of the five mRNAs (%)All of the five mRNAs (%)Anyone of the five mRNAs (%)All of the five mRNAs (%)
T3232 (100)22 (68.8)10 (31.3)0 (0)
N3224 (75.0)3 (9.4)29 (90.6)8 (25.0)
P > 0.05P > 0.05P > 0.05P > 0.05